Clinical Trial Update: A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the safety of an investigational chickenpox vaccine in healthy children aged 12 to 15 months, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chickenpox

Drugs mentioned

• Investigational varicella (chickenpox) vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chickenpox | Phase 3 | Status: RECRUITING